Target intelligence / Profile preview

Non-POU domain containing, octamer-binding pseudogene

Molecular classification
Pseudogene
01

Overview

ENSG00000260290 is a pseudogene derived from the NONO gene, which encodes the Non-POU domain-containing octamer-binding protein (NONO)[7]. Pseudogenes are DNA segments that resemble functional genes but have lost the ability to encode a functional protein, often due to mutations such as frameshifts or premature stop codons[1][3]. The parent NONO gene is involved in nuclear functions including transcription regulation, RNA splicing, and has roles in circadian rhythm and cancer biology[4][6]. However, ENSG00000260290 does not produce a protein and is not considered a direct therapeutic target or biomarker. ENSG00000260290 is not a therapeutically relevant protein or receptor. It is a pseudogene—a sequence related to the NONO gene but incapable of producing the functional NonO protein[7][1][3]. Information regarding the functional NONO gene should not be directly attributed to this pseudogene unless specifically validated by studies.

02

Mechanism of action

None, as it is not a drug target.

03

Biological functions

As a pseudogene, it has no confirmed functional protein product.Rarely, some pseudogenes may influence gene regulation (such as acting as source of regulatory RNAs), but no specific function is established for ENSG00000260290[5][3].
04

Disease associations

None specific for this pseudogene. The parent NONO gene has been implicated in cancer and RNA processing defects, but these do not apply to ENSG00000260290 itself[4][7].
05

Safety considerations

None specific, as pseudogenes are not druggable targets and generally do not produce functional products[3][1].
06

Interacting drugs

None known or reported for this pseudogene.
07

Biomarkers

No known biomarker use.

Beyond the preview

Go deeper on Non-POU domain containing, octamer-binding pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Non-POU domain containing, octamer-binding pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call